Page last updated: 2024-08-26

phorbolol myristate acetate and Bone Loss, Osteoclastic

phorbolol myristate acetate has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liu, D; Wise, GE; Yao, S	1

Other Studies

1 other study(ies) available for phorbolol myristate acetate and Bone Loss, Osteoclastic

Article	Year
Injections of osteoprotegerin and PMA delay tooth eruption. Clinical anatomy (New York, N.Y.), 2006, Volume: 19, Issue:1 Topics: Animals; Bone Resorption; Dental Sac; Dose-Response Relationship, Drug; Gene Expression; Glycoproteins; Injections, Subcutaneous; Osteoclasts; Osteoprotegerin; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Tooth Eruption	2006

Article

Year

Injections of osteoprotegerin and PMA delay tooth eruption.

Clinical anatomy (New York, N.Y.), 2006, Volume: 19, Issue:1

Topics: Animals; Bone Resorption; Dental Sac; Dose-Response Relationship, Drug; Gene Expression; Glycoproteins; Injections, Subcutaneous; Osteoclasts; Osteoprotegerin; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetradecanoylphorbol Acetate; Time Factors; Tooth Eruption

2006